Structure and Antigenic Properties
Members of the Togaviridae family are spherical viruses with a diameter of 65–70 nm. The name derives from the Latin word toga (cloak), reflecting the presence of an outer lipoprotein envelope. The genome consists of a linear positive-sense single-stranded RNA.
A key feature of the genus Alphavirus is the complete absence of a matrix (M) protein. The virion protein profile includes:
- C protein — forms the icosahedral nucleocapsid, shared across the entire genus to provide genus-specific antigenicity.
- Envelope glycoproteins (E1, E2, E3) — span the lipid envelope and determine species specificity.
- E1 — possesses hemagglutinating activity (agglutinating avian erythrocytes). Antibodies against E1 block hemagglutination but do not neutralize the virus itself.
- E2 — the primary protective antigen. This protein induces the synthesis of virus-neutralizing antibodies in the host.
- E3 — present in only some alphaviruses (e.g., part of the Semliki Forest virus complex).
Life Cycle and Stability
The life cycle of alphaviruses is rapid, taking only 6–8 hours. The virion enters the host cell via receptor-mediated endocytosis, and all replication processes occur exclusively in the cytoplasm.
Genome transcription involves the production of two types of mRNA:
- 49S mRNA — identical to the genomic RNA and serves as a template for synthesizing new genomes.
- 26S mRNA — encodes structural proteins (C, E1, E2, E3).
Nucleocapsid assembly occurs on the membranes of the endoplasmic reticulum (ER), after which virions are released via budding (exocytosis) through the plasma membrane.
Due to their lipid envelope, togaviruses are highly susceptible to lipid solvents (ether, detergents). They are rapidly inactivated by heating to 56 °C, formalin, chlorine-based disinfectants, and UV irradiation. However, they remain stable during cryopreservation and tolerate a pH range of 6.0 to 9.0.
Epidemiology and Pathogenesis
Alphavirus infections are zoonoses maintained in natural reservoirs. In these cycles, the virus circulates between vertebrate hosts (birds, rodents, primates) and mosquitoes.
Mosquitoes serve not only as vectors but also as vital viral reservoirs. Infection can be transmitted within insect populations through various routes: trans-stage (from larva to adult), transovarial (from female to offspring via eggs), alimentary, and even sexually. Humans are infected when entering a natural focus and receiving a mosquito bite. High population densities can trigger an anthroponotic transmission cycle.
Pathogenesis follows a distinct staging:
- Viral replication at the site of the bite.
- Primary (resorptive) viremia.
- Dissemination to internal organs and replication in capillary endothelium (tissue phase).
- Secondary massive viremia (clinically coinciding with fever onset).
Subsequent disease progression depends on strain tropism: vasotropic strains target blood vessels, while neurotropic strains cross the blood-brain barrier and cause neuronal cell death in the CNS.
Clinical Features, Diagnosis, and Prevention
The alphaviruses of greatest epidemiological importance include the equine encephalitis viruses (Western, Eastern, Venezuelan), as well as Chikungunya and O'nyong-nyong viruses. Infections are frequently asymptomatic, but manifest cases present with fever, exanthema (skin rash), arthralgia/arthritis, and encephalitis. Immunity following infection is long-lasting.
Diagnosis relies on virus isolation from blood or cerebrospinal fluid (via intracerebral inoculation of newborn mice or cell cultures) and serology. The standard retrospective diagnostic method is paired acute and convalescent sera testing (neutralization assay, complement fixation, hemagglutination inhibition). Rapid diagnostic methods include RT-PCR and ELISA for antigen detection.
Because alphaviruses pose a high biosafety risk (laboratory-acquired infection via aerosols), specific prophylaxis for personnel involves killed formalin-inactivated vaccines. Treatment options include antiviral drugs (e.g., ribavirin) and passive immunotherapy (convalescent sera).